TABLE 2.
Prevalence and Odds of Cost-Related Medication Nonadherence Among Respondents With Chronic Liver Disease by Incremental Burden of Concurrent Comorbid Conditions
| No. of Major Comorbid Conditionsa | Survey-Weighted Sample Size | Survey-Weighted Prevalence (95% CI) | Adjusted Odds Ratio (95% CI)b | P |
|---|---|---|---|---|
|
| ||||
| 0 | 112,325 | 19% (14%–24%) | 1 (reference) | — |
| 1 | 281,925 | 25% (21%–29%) | 1.58 (1.06–2.34) | .02 |
| 2–3 | 408,133 | 33% (29%–37%) | 2.27 (1.54–3.34) | <.001 |
| ≥4 | 81,947 | 43% (32%–54%) | 3.40 (1.93–6.01) | <.001 |
a
Values represent survey-weighted prevalence figures (or percentages); their respective 95% CIs lie within parentheses.
b
Adjusted odds ratio, 95% CI, and corresponding P value correspond to multivariate logistic regression modeling adjusted for age, sex, marital status, education, race/ethnicity, family income (greater or lesser than 200% of national poverty rate for survey year), survey region, insurance status/type, alcohol and/or tobacco use, presence of specific comorbid conditions, employment status, having paid sick leave, and welfare receipt.